2016
DOI: 10.1016/j.pharmthera.2015.12.005
|View full text |Cite
|
Sign up to set email alerts
|

Toll-like receptors mediating vascular malfunction: Lessons from receptor subtypes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
42
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 56 publications
(44 citation statements)
references
References 215 publications
0
42
0
Order By: Relevance
“…Given the likelihood of systemic suppression of TLR4 to disable responding pattern of TLR4 to invading pathogens, modulation of intestinal microbiota via probiotics and symbiotics become a preferred therapeutic strategy for liver diseases, associated with favorable tolerability and safety[13,23]. Besides, certain synthetic ligands of TLRs have been considered to act as target molecules for drug development given their effects on regulation of innate and adaptive immune responses, including TLR activators (for infections and certain cancers), TLR inhibitors (for inflammatory diseases and sepsis) as well as TLR neutralizing antibodies[34,37]. Further investigation of the role of TLR pathways in liver diseases addressing the downstream mediators and regulation of TLR signaling, the specific cell populations involved, the role of TLR polymorphisms and the mechanisms underlying liver tumorigenesis is needed to transfer knowledge on TLR pathophysiology into clinical practice in treating human liver diseases[5,23].…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…Given the likelihood of systemic suppression of TLR4 to disable responding pattern of TLR4 to invading pathogens, modulation of intestinal microbiota via probiotics and symbiotics become a preferred therapeutic strategy for liver diseases, associated with favorable tolerability and safety[13,23]. Besides, certain synthetic ligands of TLRs have been considered to act as target molecules for drug development given their effects on regulation of innate and adaptive immune responses, including TLR activators (for infections and certain cancers), TLR inhibitors (for inflammatory diseases and sepsis) as well as TLR neutralizing antibodies[34,37]. Further investigation of the role of TLR pathways in liver diseases addressing the downstream mediators and regulation of TLR signaling, the specific cell populations involved, the role of TLR polymorphisms and the mechanisms underlying liver tumorigenesis is needed to transfer knowledge on TLR pathophysiology into clinical practice in treating human liver diseases[5,23].…”
Section: Resultsmentioning
confidence: 99%
“…TLRs are a group of evolutionarily conserved type I transmembrane proteins responsible for innate immune and inflammatory responses[34-38]. They comprise an extracellular domain with receptor specific leucine-rich repeat motifs and a highly conserved cytosolic domain alike to the IL-1 receptor called TIR[13,29,36,37].…”
Section: Tlr Family Distribution Ligandsmentioning
confidence: 99%
See 2 more Smart Citations
“…They can protect the host against a vast array of microbial infections (Zhang and Liang 2016). TLR activation stimulates signaling cascades by the host as a defense mechanism against invaders and to repair the damaged tissue (Wang et al 2015). The binding of ligand to TLR resulted in the recruitment of several adaptor proteins and led to activation of many transcriptional factors which drive the expression of cytokine genes (Kawasaki and Kawai 2014).…”
Section: Introductionmentioning
confidence: 99%